# Eli Lilly’s Weight-Loss Drug Dramatically Reduces Diabetes Risk in Three-Year Trial – Study conducted by Eli Lilly shows significant results in diabetes prevention – Participants taking the weight-loss drug saw a 94% reduction in diabetes risk – The drug targets the brain’s appetite control system to promote weight loss and improve metabolic health ## In a recent three-year trial conducted by Eli Lilly, participants who took a weight-loss drug saw a remarkable 94% reduction in their risk of developing diabetes. The study focused on the drug’s ability to target the brain’s appetite control system, ultimately leading to weight loss and improved metabolic health. These findings present promising results in the prevention of diabetes, highlighting the potential impact of this drug on public health initiatives. If you are looking to reduce your risk of diabetes or improve your metabolic health, this weight-loss drug may offer a viable solution. The impressive outcomes of the trial conducted by Eli Lilly demonstrate the drug’s effectiveness in promoting weight loss and lowering the risk of developing diabetes. Taking proactive steps towards managing your weight and overall health is key, and this drug could be a valuable tool in achieving those goals. Contact Mindful Evolution today to learn more about how we can support your weight loss journey and help you improve your metabolic health through our telehealth services available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.